Suppr超能文献

术前肾功能对美国原位肝移植(OLTX)结局的持续影响:终末期肝病模型(MELD)将把我们带向何方?

Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?

作者信息

Gonwa T A, McBride M A, Anderson K, Mai M L, Wadei H, Ahsan N

机构信息

Department of Transplantation, Mayo Clinic Jacksonville, Jacksonville, Florida, USA.

出版信息

Am J Transplant. 2006 Nov;6(11):2651-9. doi: 10.1111/j.1600-6143.2006.01526.x. Epub 2006 Aug 25.

Abstract

Renal function is a component of the Model for End Stage Liver Disease (MELD), We queried the 1999-2004 OPTN/UNOS database to determine whether preoperative renal function remained an important determinant of survival in primary deceased donor liver transplant alone patients (DDLTA) or primary combined kidney liver transplant patients (KLTX). We examined preoperative creatinine, renal replacement therapy (RRT), incidence of KLTX, and patient survival in the 34 months before and after introduction of MELD and performed a multivariate Cox regression analysis of time to death. Preoperative renal function is an independent predictor of survival in DDLTA but not in KLTX. When compared to DDLTA with a preoperative serum creatinine of 0-0.99 mg/dL, patients with serum creatinine from 1-1.99 mg/dL, >2.0 mg/dL, those requiring RRT, and those receiving KLTX had a relative risk of death following transplant of 1.11, 1.58, 1.77, and 1.44 respectively. KLTX requiring RRT had better survival than DDLTA requiring RRT. Since introduction of MELD, KLTX, preoperative creatinine, and number of patients requiring preoperative RRT have increased. Despite this, patient survival following orthotopic liver transplant (OLTX) in the 34 months after introduction of MELD is not different than prior to introduction of MELD.

摘要

肾功能是终末期肝病模型(MELD)的一个组成部分。我们查询了1999 - 2004年器官共享联合网络(OPTN)/美国器官共享与移植网络(UNOS)数据库,以确定术前肾功能是否仍然是单纯原发性脑死亡供体肝移植患者(DDLTA)或原发性肝肾联合移植患者(KLTX)生存的重要决定因素。我们检查了MELD引入前后34个月内的术前肌酐、肾脏替代治疗(RRT)、KLTX发生率和患者生存率,并对死亡时间进行了多因素Cox回归分析。术前肾功能是DDLTA患者生存的独立预测因素,但在KLTX患者中并非如此。与术前血清肌酐为0 - 0.99 mg/dL的DDLTA患者相比,血清肌酐为1 - 1.99 mg/dL、>2.0 mg/dL的患者、需要RRT的患者以及接受KLTX的患者移植后死亡的相对风险分别为1.11、1.58、1.77和1.44。需要RRT的KLTX患者比需要RRT的DDLTA患者生存率更高。自MELD引入以来,KLTX、术前肌酐以及术前需要RRT的患者数量均有所增加。尽管如此,MELD引入后34个月内原位肝移植(OLTX)患者的生存率与MELD引入前并无差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验